Ocena vrednosti farmacevtskega podjetja v odvisnosti od odobritve zdravila: primer Biogen : delo diplomskega seminarja

Spiller, Ian (author), Črnigoj, Matjaž (mentor)

V diplomski nalogi sem vrednotil farmacevtsko podjetje Biogen. Za vrednotenje sem kot glavno metodo uporabil metodo diskontiranih denarnih tokov, kot kontrolno metodo pa metodo vrednotenja z mnogokratniki. Po podrobni analizi podjetja in napovedi njihovega poslovanja je moje vrednotenje pokazalo, da je Biogen morda nekoliko podcenjeno podjetje, a je razlika med tržno ceno in ocenjeno vrednostjo majhna in tako bi lahko ocenili, da je tržna vrednost podjetja prava.

• Language: Slovenian
• Keywords: prosti denarni tok, metoda diskontiranih prostih denarnih tokov, povprečna zahtevana donosnost investitorjev, Aduhelm
• Work type: Final seminar paper
• Typology: 2.11 - Undergraduate Thesis
• Organization: FMF - Faculty of Mathematics and Physics
• Year: 2022
• PID: 20.500.12556/RUL-139742
• UDC: 519.8
• COBISS.SI-ID: 120719619
• Publication date in RUL: 07.09.2022

Secondary language

• Language: English
• Title: Valuation of pharmaceutic company based on approval of new drug: Biogen

Abstract

In my dissertation I have decided to value a pharmaceutic company Biogen. My main method for valuation was discouted free cash flow method and for control method I used multiples approach. After careful financial analysis and prediction of the company business in the next five years I concluded that the company is maybe a little bit undervalued but it is such a small difference between my valuation and market price that we could conclude that market value of company is correct.

• Keywords: free cash flow, discounted free cash flow method, average weighted cost of capital, Aduhelm